Cost-effectiveness of a low-calorie diet and orlistat for obese persons: modeling long-term health gains through prevention of obesity-related chronic diseases.
Value Health
; 11(7): 1033-40, 2008 Dec.
Article
en En
| MEDLINE
| ID: mdl-18494748
ABSTRACT
OBJECTIVE:
Our study estimated the cost-effectiveness of pharmacologic treatment of obesity in combination with a low-calorie diet in The Netherlands.METHODS:
Costs and effects of a low-calorie diet-only intervention and of a low-calorie diet in combination with 1 year of orlistat were compared to no treatment. The RIVM Chronic Disease Model was used to project the differences in quality adjusted life years (QALYs) and lifetime health-care costs because of the effects of the interventions on body mass index (BMI) status. This was done by linking BMI status to the occurrence of obesity-related diseases and by relating quality of life to disease status. Probabilistic sensitivity analysis was employed to study the effect of uncertainty in the model parameters. In univariate sensitivity analysis, we assessed how sensitive the results were to several key assumptions.RESULTS:
Incremental costs per QALY gained were Euro 17,900 for the low-calorie diet-only intervention compared to no intervention and Euro 58,800 for the low-calorie diet + orlistat compared to the low-calorie diet only. Assuming a direct relation between BMI and quality of life, these ratios decreased to Euro 6000 per QALY gained and Euro 24,100 per QALY gained. Costs per QALY gained were also sensitive to assumptions about long-term weight loss maintenance.CONCLUSIONS:
Cost-effectiveness ratios of interventions aiming at weight reduction depend strongly on assumptions regarding the relation between BMI and quality of life. We recommend that a low-calorie diet should be the first option for policymakers in combating obesity.
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Años de Vida Ajustados por Calidad de Vida
/
Fármacos Antiobesidad
/
Restricción Calórica
/
Lactonas
/
Obesidad
Tipo de estudio:
Health_economic_evaluation
Límite:
Adult
/
Aged
/
Humans
/
Middle aged
Idioma:
En
Año:
2008
Tipo del documento:
Article